SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-22-005061
Filing Date
2022-12-07
Accepted
2022-12-07 16:30:57
Documents
1
Period of Report
2022-12-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5495
  Complete submission text file 0000902664-22-005061.txt   7562
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Reporting) CIK: 0001410830 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 221450505

Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MATRIX CAPITAL MANAGEMENT CO., LP 1000 WINTER STREET, SUITE 4500 WALTHAM MA 02451
Business Address
GOEL DAVID E. (Reporting) CIK: 0001548144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 221450504